WASHINGTON, D.C. — Brian Rowan and Herbert “Herb” Kimble occupied different corners of the American healthcare marketplace, promoted different medical products, and allegedly used different operational structures, yet their cases reveal striking similarities within the recurring Medicare fraud playbook pursued by federal investigators. Kimble ultimately pleaded guilty during 2019 to federal offenses involving conspiracy, healthcare fraud, wire fraud, mail fraud, false claims, kickbacks, and bribes, distinguishing his established admissions from the allegations Rowan continues to contest within an unresolved prosecution. After major enforcement actions, Medicare may impose broader restrictions that affect legitimate providers and beneficiaries, meaning one alleged network can produce consequences extending well beyond the defendants, claims, products, and patients named within an indictment. Kimble Offers a Warning, not a VerdictKimble’s case illustrates how telemarketing, remote prescribing, unnecessary medical products, kickbacks, false documentation, offshore operations, and distributed corporate roles can combine into a massive Medicare fraud system capable of operating across several years. Different Schemes, Same Medicare Fraud PlaybookKimble’s orthotics operation and Rowan’s alleged wound-allograft enterprise demonstrate how Medicare fraud can evolve around different products while retaining a familiar architecture built upon vulnerable seniors, reimbursable treatments, compromised medical judgment, financial inducements, misleading records, and divided responsibilities.